Headline

Congress yesterday passed a farm bill conference report that authorizes assistance for rural hospitals to refinance a debt obligation as an eligible loan or loan guarantee if the assistance would help preserve access to health services in a rural community and meaningfully improve the financial…

The Department of Health and Human Services’ Office for Civil Rights will accept comments through Feb. 11 on potential changes to the Health Insurance Portability and Accountability Act rules to promote coordinated, value-based care.

The House of Representatives today passed AHA-supported legislation (H.R. 1318) that would provide funding for states to develop maternal mortality review committees to better understand maternal complications and identify solutions.

Republicans on the House Energy and Commerce Committee Friday released a report summarizing initial efforts by its Oversight and Investigations Subcommittee to address the nation’s cybersecurity challenges.

The Medicare Payment Advisory Commission this week discussed several draft recommendations for Congress, which the panel could vote on in January.

U.S. spending on health care grew 3.9 percent in 2017, down from 4.8 percent in 2016 and less than the growth in the overall economy, primarily due to slower growth in spending for hospital care, physician and clinical services, and retail prescription drugs.

A coalition of 29 health care and public health organizations, including the AHA, today urged Congress to pass the Pandemic and All-Hazards Preparedness & Advancing Innovation Act (S. 2852/H.R. 6378) before Congress adjourns for 2018.

The AHA, jointly filed a lawsuit against the Department of Health and Human Services for finalizing a policy to phase-in a reduction in payments for hospital outpatient clinic visit services furnished in off-campus provider-based departments that are grandfathered under Section 603 of the…

The Senate Health, Education, Labor and Pensions Committee today held the fifth in a series of hearings on reducing health care costs, which focused on improving affordability through innovation.  

The Food and Drug Administration intends to finalize guidance early next year on a new approach to its 510(k) program for pre-market review of medical devices.